Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV6 | Q9H1D0 | 6/20 | 1.00 |
| ▸ | ORAI1 | Q96D31 | 5/20 | 1.00 |
| ▸ | ORAI2 | Q96SN7 | 5/20 | 1.00 |
| ▸ | ORAI3 | Q9BRQ5 | 5/20 | 1.00 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 3/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.35 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.35 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.35 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.35 |
| ▸ | PLAU | P00749 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4833078 | 0.87 | TRPV6 (0.76) | TRPV6ORAI1ORAI2ORAI3PCSK9 | |
| SCHEMBL23219856 | 0.83 | TRPV6 (0.70) | TRPV6ORAI1ORAI2ORAI3PCSK9 | |
| SCHEMBL5164042 | 0.82 | ORAI1 (0.67) | TRPV6ORAI1ORAI2ORAI3CA1 | |
| SCHEMBL5508 | 0.81 | ORAI1 (0.68) | TRPV6ORAI1ORAI2ORAI3CA1 | |
| SCHEMBL21979751 | 0.81 | ORAI1 (0.68) | TRPV6ORAI1ORAI2ORAI3CA1 | |
| SCHEMBL16653115 | 0.80 | TRPV6 (0.67) | TRPV6ORAI1ORAI2ORAI3PCSK9 | |
| SCHEMBL18839425 | 0.79 | ORAI1 (0.65) | TRPV6ORAI1ORAI2ORAI3CA1 | |
| SCHEMBL1138738 | 0.79 | ORAI1 (0.65) | TRPV6ORAI1ORAI2ORAI3CA1 | |
| SCHEMBL5167645 | 0.77 | TRPV6 (0.59) | TRPV6ORAI1ORAI2ORAI3PCSK9 | |
| SCHEMBL2551749 | 0.75 | CA2 (0.61) | TRPV6ORAI1ORAI2ORAI3CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3521358-B1 | USE OF A CROSSLINKABLE COMPOUND RUBBER COMPOSITION FOR THE COLD RETREADING OF A TYRE | CONTINENTAL REIFEN DEUTSCHLAND GMBH (DE) | 2021-11-10 | — | — | EP | claimed |
| EP-3541634-B1 | TIRE COMPRISING A TREAD COMPRISING A THERMOPLASTIC ELASTOMER AND A CROSSLINKING SYSTEM BASED ON SULFUR | MICHELIN & CIE (FR) | 2020-12-30 | — | — | EP | claimed |
| EP-3521358-A1 | COMPOUND RUBBER COMPOSITION AND METHOD FOR PREPARING A CROSSLINKABLE COMPOUND RUBBER COMPOSITION, AND USE OF THE COMPOUND RUBBER COMPOSITION | Continental Reifen Deutschland GmbH (DE) | 2019-08-07 | — | — | EP | claimed |
| EP-2978803-B1 | PROCESS FOR CROSSLINKING EPM AND EPDM | AKZO NOBEL CHEMICALS INT BV (NL) | 2017-05-03 | — | — | EP | claimed |
| EP-0695780-B2 | Rubber composition free of carcinogenic nitrosamine precursors and suitable as joining material | MICHELIN & CIE (FR) | 2006-12-27 | — | — | EP | claimed |
| EP-0695780-B1 | Rubber composition free of carcinogenic nitrosamine precursors and suitable as joining material | MICHELIN & CIE (FR) | 2000-10-25 | — | — | EP | claimed |
| EP-0690091-B1 | Improvements in and relating to the reclaiming of natural and synthetic rubbers | SEKHAR B C SDN BHD (MY) | 1999-09-15 | — | — | EP | claimed |
| US-5591726-A | Heterocyclylalkyl diarylboron ester and thioester fungicidal agents | AMERICAN CYANAMID COMPANY (US) | 1997-01-07 | — | — | US | claimed |
| US-20260050210-A1 | RESIST COMPOSITION AND METHOD FOR PRODUCING SAME | NIPPON SHOKUBAI CO., LTD. (JP) | 2026-02-19 | — | — | US | disclosed |
| EP-3521358-B1 | USE OF A CROSSLINKABLE COMPOUND RUBBER COMPOSITION FOR THE COLD RETREADING OF A TYRE | CONTINENTAL REIFEN DEUTSCHLAND GMBH (DE) | 2021-11-10 | — | — | EP | disclosed |
| EP-2451767-B1 | METHOD FOR PRODUCING (2,4-DIMETHYLBIPHENYL-3-YL) ACETIC ACIDS, ESTERS THEREOF AND INTERCONNECTIONS | BAYER CROPSCIENCE AG (DE) | 2019-08-21 | — | — | EP | disclosed |
| EP-3521358-A1 | COMPOUND RUBBER COMPOSITION AND METHOD FOR PREPARING A CROSSLINKABLE COMPOUND RUBBER COMPOSITION, AND USE OF THE COMPOUND RUBBER COMPOSITION | Continental Reifen Deutschland GmbH (DE) | 2019-08-07 | — | — | EP | disclosed |
| US-8664428-B2 | Method for producing (2,4-dimethylbiphenyl-3-yl)acetic acids, the esters thereof and intermediate compounds | BAYER CROPSCIENCE AG (DE) | 2014-03-04 | — | — | US | disclosed |
| EP-2451767-A2 | METHOD FOR PRODUCING (2,4-DIMETHYLBIPHENYL-3-YL)ACETIC ACIDS, THE ESTERS THEREOF AND INTERMEDIATE COMPOUNDS | Bayer CropScience AG (DE) | 2012-05-16 | — | — | EP | disclosed |
| EP-1003753-B1 | COMPOUNDS CONTAINING BORON AND ALUMINIUM | BASELL POLYOLEFINE GMBH (DE) | 2003-03-05 | — | — | EP | disclosed |
| US-6417302-B1 | REACTION PRODUCT OF DI(PENTAFLUOROPHENYL) BORINIC ACID AND ORGANOALUMINUM COMPOUND; OLEFIN POLYMERIZATION COORDINATION CATALYSTS | BASELL POLYOLEFINE GMBH (DE) | 2002-07-09 | — | — | US | disclosed |
| WO-2002044184-A2 | DNA METHYL TRANSFERASE INHIBITORS | THE PENN STATE RESEARCH FOUNDATION (US) | 2002-06-06 | — | — | WO | disclosed |
| EP-1142869-A2 | Process for the preparation of zinc dithiocarbamates | BAYER AG (DE) | 2001-10-10 | — | — | EP | disclosed |
| US-5591726-A | Heterocyclylalkyl diarylboron ester and thioester fungicidal agents | AMERICAN CYANAMID COMPANY (US) | 1997-01-07 | — | — | US | disclosed |
| EP-0703235-A2 | Heterocyclylalkyl diarylboron ester and thioester fungicidal agents | AMERICAN CYANAMID COMPANY (US) | 1996-03-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260050210-A1 | RESIST COMPOSITION AND METHOD FOR PRODUCING SAME | MAL2, MCM6, MCM3 | TRPV6 2089/4885ORAI1 505/4885ORAI2 712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.